Steven D Leach

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Are you Steven D Leach?

Claim your profile

Publications (160)1254 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Development of the pancreas and cerebellum require Pancreas-specific transcription factor 1a (Ptf1a), which encodes a subunit of the transcription factor complex PTF1. Ptf1a is required in succession for specification of the pancreas, proper allocation of pancreatic progenitors to endocrine and exocrine fates, and the production of digestive enzymes from the exocrine acini. In several neuronal structures, including the cerebellum, hindbrain, retina and spinal cord, Ptf1a is transiently expressed and promotes inhibitory neuron fates at the expense of excitatory fates. Transcription of Ptf1a in mouse is maintained in part by PTF1 acting on an upstream autoregulatory enhancer. However, the transcription factors and enhancers that initially activate Ptf1a expression in the pancreas and in certain structures of the nervous system have not yet been identified. Here we describe a zebrafish autoregulatory element, conserved among teleosts, with activity similar to that described in mouse. In addition, we performed a comprehensive survey of all non-coding sequences in a 67 kilobase interval encompassing zebrafish ptf1a, and identified several neuronal enhancers, and an enhancer active in the ventral pancreas prior to activation of the autoregulatory enhancer. To test the requirement for autoregulatory control during pancreatic development, we restored ptf1a function through BAC transgenesis in ptf1a morphants, either with an intact BAC or one lacking the autoregulatory enhancer. We find that ptf1a autoregulation is required for development of the exocrine pancreas and full rescue of the ptf1a morphant phenotype. Similarly, we demonstrate that a ptf1a locus lacking the early enhancer region is also capable of rescue, but only supports formation of a hypoplastic exocrine pancreas. Through our dissection of the complex regulatory control of ptf1a, we identified separate cis-regulatory elements that underlie different aspects of its expression and function, and further demonstrated the requirement of maintained ptf1a expression for normal pancreatic morphogenesis. We also identified a novel enhancer that mediates initiation of ptf1a expression in the pancreas, through which the signals that specify the ventral pancreas are expected to exert their action.
    Preview · Article · Jul 2013 · Developmental Biology
  • Philip Borden · Jessica Houtz · Steven D Leach · Rejji Kuruvilla
    [Show abstract] [Hide abstract]
    ABSTRACT: Sympathetic neurons depend on target-derived neurotrophic cues to control their survival and growth. However, whether sympathetic innervation contributes reciprocally to the development of target tissues is less clear. Here, we report that sympathetic innervation is necessary for the formation of the pancreatic islets of Langerhans and for their functional maturation. Genetic or pharmacological ablation of sympathetic innervation during development resulted in altered islet architecture, reduced insulin secretion, and impaired glucose tolerance in mice. Similar defects were observed with pharmacological blockade of β-adrenergic signaling. Conversely, the administration of a β-adrenergic agonist restored islet morphology and glucose tolerance in deinnervated animals. Furthermore, in neuron-islet cocultures, sympathetic neurons promoted islet cell migration in a β-adrenergic-dependent manner. This study reveals that islet architecture requires extrinsic inductive cues from neighboring tissues such as sympathetic nerves and suggests that early perturbations in sympathetic innervation might underlie metabolic disorders.
    No preview · Article · Jul 2013 · Cell Reports
  • [Show abstract] [Hide abstract]
    ABSTRACT: Unlabelled: Patient-specific induced pluripotent stem cells (iPSCs) represent a potential source for developing novel drug and cell therapies. Although increasing numbers of disease-specific iPSCs have been generated, there has been limited progress in iPSC-based drug screening/discovery for liver diseases, and the low gene-targeting efficiency in human iPSCs warrants further improvement. Using iPSC lines from patients with alpha-1 antitrypsin (AAT) deficiency, for which there is currently no drug or gene therapy available, we established a platform to discover new drug candidates and correct disease-causing mutation with a high efficiency. A high-throughput format screening assay, based on our hepatic differentiation protocol, was implemented to facilitate automated quantification of cellular AAT accumulation using a 96-well immunofluorescence reader. To expedite the eventual application of lead compounds to patients, we conducted drug screening utilizing our established library of clinical compounds (the Johns Hopkins Drug Library) with extensive safety profiles. Through a blind large-scale drug screening, five clinical drugs were identified to reduce AAT accumulation in diverse patient iPSC-derived hepatocyte-like cells. In addition, using the recently developed transcription activator-like effector nuclease technology, we achieved high gene-targeting efficiency in AAT-deficiency patient iPSCs with 25%-33% of the clones demonstrating simultaneous targeting at both diseased alleles. The hepatocyte-like cells derived from the gene-corrected iPSCs were functional without the mutant AAT accumulation. This highly efficient and cost-effective targeting technology will broadly benefit both basic and translational applications. Conclusions: Our results demonstrated the feasibility of effective large-scale drug screening using an iPSC-based disease model and highly robust gene targeting in human iPSCs, both of which are critical for translating the iPSC technology into novel therapies for untreatable diseases.
    No preview · Article · Jun 2013 · Hepatology
  • Elayne Provost · Christopher A Weier · Steven D Leach
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Ribosomal protein L (rpl) genes are essential for assembly of the 60S subunit of the eukaryotic ribosome and may also carry out additional extra-ribosomal functions. We have identified a common expression pattern for rpl genes in developing zebrafish larvae. After initially widespread expression in early embryos, the expression of multiple rpl genes becomes increasingly restricted to the endoderm. With respect to the pancreas, rpl genes are highly expressed in ptf1a-expressing pancreatic progenitors at 48 hpf, suggesting possible functional roles in pancreatic morphogenesis and/or differentiation. Utilizing two available mutant lines, rpl23a(hi2582) and rpl6(hi3655b), we found that ptf1a-expressing pancreatic progenitors fail to properly expand in embryos homozygous for either of these genes. In addition to these durable homozygous phenotypes, we also demonstrated recoverable delays in ptf1a-expressing pancreatic progenitor expansion in rpl23a(hi2582) and rpl6(hi3655b) heterozygotes. Disruptions in ribosome assembly are generally understood to initiate a p53-dependent cellular stress response. However, concomitant p53 knockdown was unable to rescue normal pancreatic progenitor expansion in either rpl23a(hi2582) or rpl6(hi3655b) mutant embryos, suggesting required and p53-independent roles for rpl23a and rpl6 in pancreas development.
    No preview · Article · May 2013 · Zebrafish

  • No preview · Article · May 2013 · Gastroenterology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sphere-forming assays are an in vitro technique to assay both normal and neoplastic cells for clonogenic growth potential. Currently, the identification of adult progenitors in the pancreas remains an area of intense investigation. The use of sphere-forming assays provides a critical step to identify new cell types in the pancreas that are capable of clonogenic growth and differentiation. In the field of cancer biology, cancer stem cells have been defined functionally by two major criteria: their ability to undergo self-renewal and their ability to produce differentiated progeny, two conditions which satisfy the criteria of stem cells. Here we briefly review both the capabilities of pancreatosphere and pancreatic tumorsphere assays, discuss important caveats regarding their use, and provide detailed protocols for the assay of both normal and neoplastic cells.
    No preview · Article · Jan 2013 · Methods in molecular biology (Clifton, N.J.)
  • Source
    Anirban Maitra · Steven D Leach
    [Show abstract] [Hide abstract]
    ABSTRACT: In this issue of Cancer Cell, Kopp and colleagues report that pancreatic ductal cells are largely refractory to the induction of pancreatic neoplasia. Whereas a rare ductal subpopulation may still prove capable of neoplastic transformation, these findings refocus attention on acinar and other non-ductal cell types as initiators of this deadly neoplasm.
    Preview · Article · Dec 2012 · Cancer cell
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mutations in the human Shwachman-Bodian-Diamond syndrome (SBDS) gene cause defective ribosome assembly and are associated with exocrine pancreatic insufficiency, chronic neutropenia and skeletal defects. However, the mechanism underlying these phenotypes remains unclear. Here we show that knockdown of the zebrafish sbds ortholog fully recapitulates the spectrum of developmental abnormalities observed in the human syndrome, and further implicate impaired proliferation of ptf1a-expressing pancreatic progenitor cells as the basis for the observed pancreatic phenotype. It is thought that diseases of ribosome assembly share a p53-dependent mechanism. However, loss of p53 did not rescue the developmental defects associated with loss of zebrafish sbds. To clarify the molecular mechanisms underlying the observed organogenesis defects, we performed transcriptional profiling to identify candidate downstream mediators of the sbds phenotype. Among transcripts displaying differential expression, functional group analysis revealed marked enrichment of genes related to ribosome biogenesis, rRNA processing and translational initiation. Among these, ribosomal protein L3 (rpl3) and pescadillo (pes) were selected for additional analysis. Similar to knockdown of sbds, knockdown or mutation of either rpl3 or pes resulted in impaired expansion of pancreatic progenitor cells. The pancreatic phenotypes observed in rpl3- and pes-deficient embryos were also independent of p53. Together, these data suggest novel p53-independent roles for ribosomal biogenesis genes in zebrafish pancreas development.
    No preview · Article · Sep 2012 · Development
  • [Show abstract] [Hide abstract]
    ABSTRACT: Feeling a bit cagey: morpholino-based antisense reagents have been caged through oligonucleotide cyclization, enabling photocontrol of gene expression in zebrafish embryos and larvae. Using these reagents, the timing of exocrine cell fate commitment in the developing pancreas has been examined.
    No preview · Article · Jul 2012 · Angewandte Chemie International Edition
  • [Show abstract] [Hide abstract]
    ABSTRACT: This review summarizes our current understanding of exocrine pancreas development, including the formation of acinar, ductal and centroacinar cells. We discuss the transcription factors associated with various stages of exocrine differentiation, from multipotent progenitor cells to fully differentiated acinar and ductal cells. Within the branching epithelial tree of the embryonic pancreas, this involves the progressive restriction of multipotent pancreatic progenitor cells to either a central "trunk" domain giving rise to the islet and ductal lineages, or a peripheral "tip" domain giving rise to acinar cells. This review also discusses the soluble morphogens and other signaling pathways that influence these events. Finally, we examine centroacinar cells as an enigmatic pancreatic cell type whose lineage remains uncertain, and whose possible progenitor capacities continue to be explored.
    No preview · Article · Jun 2012 · Seminars in Cell and Developmental Biology

  • No preview · Article · Apr 2012 · Cancer Research
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dicer is a ribonuclease whose major role is to generate mature microRNAs, although additional functions have been proposed. Deletion of Dicer leads to embryonic lethality in mice. To study the role of Dicer in adults, we generated mice in which administration of tamoxifen induces deletion of Dicer. Surprisingly, disruption of Dicer in adult mice induced lipid accumulation in the small intestine. To dissect the underlying mechanisms, we carried out miRNA, mRNA, and proteomic profiling of the small intestine. The proteomic analysis was done using mice metabolically labeled with heavy lysine (SILAC mice) for an in vivo readout. We identified 646 proteins, of which 80 were up-regulated >2-fold and 75 were down-regulated. Consistent with the accumulation of lipids, Dicer disruption caused a marked decrease of microsomal triglyceride transfer protein, long-chain fatty acyl-CoA ligase 5, fatty acid binding protein, and very-long-chain fatty acyl-CoA dehydrogenase, among others. We validated these results using multiple reaction monitoring (MRM) experiments by targeting proteotypic peptides. Our data reveal a previously unappreciated role of Dicer in lipid metabolism. These studies demonstrate that a systems biology approach by integrating mouse models, metabolic labeling, gene expression profiling, and quantitative proteomics can be a powerful tool for understanding complex biological systems.
    Full-text · Article · Feb 2012 · Journal of Proteome Research
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Metastasis is the leading cause of cancer-associated death but has been difficult to study because it involves a series of rare, stochastic events. To capture these events, we developed a sensitive method to tag and track pancreatic epithelial cells in a mouse model of pancreatic cancer. Tagged cells invaded and entered the bloodstream unexpectedly early, before frank malignancy could be detected by rigorous histologic analysis; this behavior was widely associated with epithelial-to-mesenchymal transition (EMT). Circulating pancreatic cells maintained a mesenchymal phenotype, exhibited stem cell properties, and seeded the liver. EMT and invasiveness were most abundant at inflammatory foci, and induction of pancreatitis increased the number of circulating pancreatic cells. Conversely, treatment with the immunosuppressive agent dexamethasone abolished dissemination. These results provide insight into the earliest events of cellular invasion in situ and suggest that inflammation enhances cancer progression in part by facilitating EMT and entry into the circulation.
    Full-text · Article · Jan 2012 · Cell
  • Jennifer M. Bailey · Steven D. Leach
    [Show abstract] [Hide abstract]
    ABSTRACT: Pancreatic cancer is an extremely aggressive disease characterized by a complex stromal or desmoplastic response. This dense desmoplastic response is in part the result of pancreatic stellate cell activation in response to paracrine signals from pre- neoplastic and neoplastic pancreatic epithelium. Activated stellate cells secrete a large array of soluble factors that directly influence malignant epithelial, vascular and inflammatory cells, and also alter the composition of the extracellular matrix. Thus, the signaling interactions between tumor and stellate cells represent a large, diverse spectrum of bidirectional and reciprocal influences necessary for the initiation and promotion of pancreatic cancer. A number of pathways including Hedgehog, Notch and Transforming growth factor-beta are involved in mediating cross-talk between the malignant pancreatic epithelium and its associated stroma, making them unique pathways to target for the treatment of pancreatic cancer.
    No preview · Chapter · Jan 2012
  • Shu Liu · Steven D Leach
    [Show abstract] [Hide abstract]
    ABSTRACT: Pancreatic cancer is a genetic disease in which somatic mutations in the KRAS proto-oncogene are detected in a majority of tumors. KRAS mutations represent an early event during pancreatic tumorigenesis, crucial for cancer initiation and progression. Recent studies, including comprehensive sequencing of the pancreatic cancer exome, have implicated the involvement of a number of additional core signaling pathways during pancreatic tumorigenesis. Improving our understanding of genetic interactions between KRAS and these additional pathways represents a critical challenge, as these interactions may provide novel opportunities for diagnosis and treatment. However, studying these interactions requires the expression of multiple transgenes in relevant cell types, an effort that has proven very difficult to achieve using gene targeted mice and is also technically challenging in zebrafish. Based on the ability of the Gal4 transcriptional activator to drive the expression of multiple transgenes under regulation of UAS (upstream activator sequence) regulatory elements, the Gal4/UAS system represents an attractive strategy for the study of genetic interactions. In this chapter, we review our experience using the Gal4/UAS system to model KRAS-initiated pancreatic cancer in zebrafish, as well as our early efforts using this system to study the influence of other cooperating oncogenes. We also describe techniques used to identify and characterize pancreatic tumors in adult transgenic fish.
    No preview · Article · Dec 2011 · Methods in cell biology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The intracellular protein p120ctn controls cell–cell adhesion by regulation of E-cadherin stability. p120ctn binds to the juxtamembrane region of E-cadherin and regulates its retention at the cell–cell surface. Mice null for p120ctn are not viable. Using Pdx1:Cre and a conditional allele of p120ctn, we deleted p120ctn in all epithelial lineages of the developing mouse pancreas: islet, acinar, and ductal. Loss of p120ctn in the developing pancreas results in expansion of ductal epithelia and loss of acinar cells. Defects in branching morphogenesis are evident at E12.5. During development the phenotype becomes more severe, ultimately resulting in a pancreas comprised primarily of abnormal ductal tissue. Pdx1:Cre; p120ctn fl/fl animals are born dead. Loss of p120ctn results in mislocalization of E-cadherin and loss of b-catenin. Additionally, at E17.5 we observed broad expression of Sox9 and Pdx in Pdx1:Cre; p120ctn fl/fl animals. This suggests inappropriate persistence of progenitor cells at late developmental timepoints. Taken together, our data demonstrates an essential role for p120ctn in pancreatic acinar cell development and differentiation.
    Full-text · Conference Paper · Aug 2011
  • Source

    Preview · Article · Aug 2011 · Developmental Biology
  • Source
    Bidyut Ghosh · Steven D Leach
    [Show abstract] [Hide abstract]
    ABSTRACT: Comment on: Andreia V. Pinho, et al. Cell Cycle 2011; 10: In press.
    Preview · Article · Jun 2011 · Cell cycle (Georgetown, Tex.)

  • No preview · Article · Apr 2011 · Cancer Research
  • Shu Liu · Steven D Leach
    [Show abstract] [Hide abstract]
    ABSTRACT: First established as a valuable vertebrate model system for studying development, zebrafish have emerged as an attractive animal system for modeling human cancers. Major technical advances have been essential for the generation of zebrafish cancer models relevant to human diseases. These models develop tumors in various organ sites that bear striking resemblance to human malignances, both histologically and genetically. Thus, the focus of cancer research in zebrafish has transcended the need to validate zebrafish as a viable model organism to study cancer biology. With the significant advantages of in vivo imaging, the power of forward genetics, well-established high efficiency for transgenesis, and ease of transplantation, further exploration of the zebrafish cancer models not only will generate unique insights into underlying mechanisms of cancer but will also provide platforms useful for drug discovery.
    No preview · Article · Feb 2011 · Annual Review of Pathology Mechanisms of Disease

Publication Stats

10k Citations
1,254.00 Total Impact Points

Institutions

  • 2014-2015
    • Memorial Sloan-Kettering Cancer Center
      • Department of Pathology
      New York, New York, United States
  • 2001-2015
    • Johns Hopkins University
      • • Department of Surgery
      • • McKusick-Nathans Institute of Genetic Medicine
      • • Department of Cell Biology
      Baltimore, Maryland, United States
  • 2003-2013
    • Johns Hopkins Medicine
      • • McKusick-Nathans Institute of Genetic Medicine
      • • Department of Surgery
      • • Department of Cell Biology
      • • Division of General Surgery and Surgical Oncology
      Baltimore, MD, United States
  • 2008
    • Philipps University of Marburg
      Marburg, Hesse, Germany
    • Bryn Mawr College
      • Department of Biology
      Bryn Mawr, Pennsylvania, United States
  • 1997-2005
    • Vanderbilt University
      • • Department of Surgery
      • • Department of Radiology and Radiological Sciences
      • • Division of Surgical Oncology
      Nashville, MI, United States
    • University of Houston
      Houston, Texas, United States
  • 2004
    • University Pompeu Fabra
      Barcino, Catalonia, Spain
  • 1997-2001
    • Gateway-Vanderbilt Cancer Treatment Center
      Clarksville, Tennessee, United States
  • 1995-1996
    • University of Texas MD Anderson Cancer Center
      • Department of Surgical Oncology
      Houston, TX, United States